Analyze Diet
Equine veterinary journal1976; 8(2); 58-65; doi: 10.1111/j.2042-3306.1976.tb03291.x

Serological detection of equid herpesvirus 1 infections of the respiratory tract.

Abstract: An investigation was made of 3 serological tests (virus neutralization, complement fixation and indirect immunofluorescence), which are applicable to epidemiological studies of infections by Equid herpesvirus 1 (EHV-1). Sera from gnotobiotic foals inoculated intranasally with various strains of EHV-1 were unable in some cases to neutralize heterologous strains and these results were not consistent with the existence of clearly-defined subtypes of EHV-1, as previously proposed. The cross-reactions in complement-fixation tests paralleled those with neutralization but immunofluorescence tests were found to be both more sensitive and more broadly reactive than the other two. Complement-fixing antibodies declined more rapidly following experimental infection than did those measured by neutralization or immunofluorescence. The results are discussed in relation to the diagnosis of EHV-1 infection and the significance they may have for the epidemiology of this disease.
Publication Date: 1976-04-01 PubMed ID: 177281DOI: 10.1111/j.2042-3306.1976.tb03291.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on the comparison of three serological tests, namely virus neutralization, complement fixation, and indirect immunofluorescence, to study Equid herpesvirus 1 (EHV-1) infections in horses. The goal was to evaluate their sensitivity and efficiency in detecting the virus, with implications for diagnosing EHV-1 and understanding its epidemiology.

Introduction and Methodology

  • This research undertakes an investigation of three serological tests – virus neutralization, complement fixation, and indirect immunofluorescence – to study the epidemiology of EHV-1 infections.
  • Serological tests are diagnostic methods used to identify antibodies in the serum, providing insight into an individual’s exposure to a particular infectious agent, in this case, EHV-1.
  • The researchers used sera (the clear liquid part of the blood) from gnotobiotic foals (foals in a completely sterile environment) that were intranasally inoculated with different strains of EHV-1.

Findings and Results

  • The sera from foals could not neutralize certain heterologous strains. This outcome aligns inconsistently with the existence of distinctly defined EHV-1 subtypes.
  • These results show that cross-reactions in the complement-fixation test were similar to those found in neutralization. However, the indirect immunofluorescence tests proved more sensitive and reactive than the other two tests.
  • It was also found that complement-fixing antibodies declined more rapidly after the infection than those detected by neutralization or immunofluorescence.
  • This suggests that while the indirect immunofluorescence test may be more broadly applicable and more sensitive to EHV-1, the complement-fixation test provides higher specificity for detecting and tracking the stage of EHV-1 infection.

Implications and Conclusion

  • The study sheds important light on the diagnosis methods of EHV-1 infection, which can influence the treatment and management of outbreaks in equine populations.
  • The results’ implications may impact understanding of the epidemiology of EHV-1 – detailing how the virus spreads among horses, its prevalence, and how it might be halted.

Cite This Article

APA
Thomson GR, Mumford JA, Campbell J, Griffiths L, Clapham P. (1976). Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Vet J, 8(2), 58-65. https://doi.org/10.1111/j.2042-3306.1976.tb03291.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 8
Issue: 2
Pages: 58-65

Researcher Affiliations

Thomson, G R
    Mumford, J A
      Campbell, J
        Griffiths, L
          Clapham, P

            MeSH Terms

            • Animals
            • Complement Fixation Tests
            • Cross Reactions
            • Fluorescent Antibody Technique
            • Herpesviridae
            • Herpesviridae Infections / diagnosis
            • Herpesviridae Infections / immunology
            • Herpesviridae Infections / veterinary
            • Herpesvirus 1, Equid / immunology
            • Horse Diseases / diagnosis
            • Horse Diseases / immunology
            • Horses
            • Neutralization Tests
            • Respiratory Tract Infections / diagnosis
            • Respiratory Tract Infections / immunology
            • Respiratory Tract Infections / veterinary

            Citations

            This article has been cited 20 times.
            1. Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortázar C, Herskin M, Michel V, Miranda Chueca MÁ, Roberts HC, Padalino B, Pasquali P, Spoolder H, Ståhl K, Calvo AV, Viltrop A, Winckler C, Carvelli A, Paillot R, Broglia A, Kohnle L, Baldinelli F, Van der Stede Y. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.. EFSA J 2022 Jan;20(1):e07036.
              doi: 10.2903/j.efsa.2022.7036pubmed: 35035581google scholar: lookup
            2. Back H, Weld J, Walsh C, Cullinane A. Equine Rhinitis A Virus Infection in Thoroughbred Racehorses-A Putative Role in Poor Performance?. Viruses 2019 Oct 18;11(10).
              doi: 10.3390/v11100963pubmed: 31635401google scholar: lookup
            3. Laing G, Christley R, Stringer A, Aklilu N, Ashine T, Newton R, Radford A, Pinchbeck G. Respiratory disease and sero-epidemiology of respiratory pathogens in the working horses of Ethiopia.. Equine Vet J 2018 Nov;50(6):793-799.
              doi: 10.1111/evj.12834pubmed: 29574904google scholar: lookup
            4. Back H, Penell J, Pringle J, Isaksson M, Ronéus N, Treiberg Berndtsson L, Ståhl K. A longitudinal study of poor performance and subclinical respiratory viral activity in Standardbred trotters.. Vet Rec Open 2015;2(1):e000107.
              doi: 10.1136/vetreco-2014-000107pubmed: 26392904google scholar: lookup
            5. Bannai H, Nemoto M, Tsujimura K, Yamanaka T, Kondo T, Matsumura T. Improving a Complement-fixation Test for Equine Herpesvirus Type-1 by Pretreating Sera with Potassium Periodate to Reduce Non-specific Hemolysis.. J Equine Sci 2013;24(4):71-4.
              doi: 10.1294/jes.24.71pubmed: 24834005google scholar: lookup
            6. Goodman LB, Wimer C, Dubovi EJ, Gold C, Wagner B. Immunological correlates of vaccination and infection for equine herpesvirus 1.. Clin Vaccine Immunol 2012 Feb;19(2):235-41.
              doi: 10.1128/CVI.05522-11pubmed: 22205656google scholar: lookup
            7. Wood JL, Newton JR, Chanter N, Mumford JA. Association between respiratory disease and bacterial and viral infections in British racehorses.. J Clin Microbiol 2005 Jan;43(1):120-6.
              doi: 10.1128/JCM.43.1.120-126.2005pubmed: 15634959google scholar: lookup
            8. Singh BK, Ahuja S, Gulati BR. Development of a neutralizing monoclonal antibody-based blocking ELISA for detection of equine herpesvirus 1 antibodies.. Vet Res Commun 2004 Jul;28(5):437-46.
            9. Singh BK, Yadav MP, Tewari SC. Neutralizing and complement-fixing monoclonal antibodies as an aid to the diagnosis of equine herpesvirus-1 infection.. Vet Res Commun 2001 Dec;25(8):675-86.
              doi: 10.1023/a:1012747331088pubmed: 11767013google scholar: lookup
            10. Tewari D, Gibson JS, Slater JD, O'Neill T, Hannant D, Allen GP, Field HJ. Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1.. Arch Virol 1993;132(1-2):101-20.
              doi: 10.1007/BF01309846pubmed: 8394686google scholar: lookup
            11. Sinclair R, Binns MM, Chirnside ED, Mumford JA. Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.. J Clin Microbiol 1993 Feb;31(2):265-71.
              doi: 10.1128/jcm.31.2.265-271.1993pubmed: 8381809google scholar: lookup
            12. Sinclair R, Moult BJ, Mumford JA. Characterization of an antigenic site on glycoprotein 13 (gC) of equid herpesvirus type-1.. Arch Virol 1993;129(1-4):327-36.
              doi: 10.1007/BF01316908pubmed: 7682404google scholar: lookup
            13. Wilson L, Neilan J, Brady I, Coyle D, Cullinane AA. Use of lambda gt11 to identify antigenic components of equine herpesvirus 4.. Virus Genes 1994 Mar;8(2):159-63.
              doi: 10.1007/BF01703073pubmed: 7521096google scholar: lookup
            14. Studdert MJ. Restriction endonuclease DNA fingerprinting of respiratory, foetal and perinatal foal isolates of equine herpesvirus type 1.. Arch Virol 1983;77(2-4):249-58.
              doi: 10.1007/BF01309272pubmed: 6314938google scholar: lookup
            15. Patel JR, Edington N, Mumford JA. Variation in cellular tropism between isolates of equine herpesvirus-1 in foals.. Arch Virol 1982;74(1):41-51.
              doi: 10.1007/BF01320781pubmed: 6297429google scholar: lookup
            16. Chowdhury SI, Kubin G, Ludwig H. Equine herpesvirus type 1 (EHV-1) induced abortions and paralysis in a Lipizzaner stud: a contribution to the classification of equine herpesviruses.. Arch Virol 1986;90(3-4):273-88.
              doi: 10.1007/BF01317376pubmed: 3015084google scholar: lookup
            17. Edington N, Bridges CG, Patel JR. Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke.. Arch Virol 1986;90(1-2):111-24.
              doi: 10.1007/BF01314149pubmed: 3015074google scholar: lookup
            18. Bridges CG, Edington N. Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection.. Clin Exp Immunol 1987 Nov;70(2):276-82.
              pubmed: 2827921
            19. Bridges CG, Edington N. Innate immunity during Equid herpesvirus 1 (EHV-1) infection.. Clin Exp Immunol 1986 Jul;65(1):172-81.
              pubmed: 2431815
            20. Gibson JS, Slater JD, Awan AR, Field HJ. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation.. Arch Virol 1992;123(3-4):351-66.
              doi: 10.1007/BF01317269pubmed: 1314051google scholar: lookup